Cargando…
Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence
INTRODUCTION: Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC) in ∼30% of all infected individuals. Here, we present a case of PASC in a patient with rheumatoid arthritis characterized by viral persistence in the nasopharynx for 6 months after acute infection. We demonstrate transie...
Autores principales: | Visvabharathy, Lavanya, Orban, Zachary S., Koralnik, Igor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537824/ https://www.ncbi.nlm.nih.gov/pubmed/36213654 http://dx.doi.org/10.3389/fmed.2022.1003103 |
Ejemplares similares
-
SARS-CoV-2–Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19
por: Orban, Zachary S., et al.
Publicado: (2023) -
T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID
por: Visvabharathy, Lavanya, et al.
Publicado: (2022) -
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
por: Hanson, Barbara A., et al.
Publicado: (2022) -
Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID
por: Visvabharathy, L, et al.
Publicado: (2023) -
Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein
por: Visvabharathy, Lavanya, et al.
Publicado: (2023)